786 related articles for article (PubMed ID: 12506037)
1. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide.
Krampera M; Glennie S; Dyson J; Scott D; Laylor R; Simpson E; Dazzi F
Blood; 2003 May; 101(9):3722-9. PubMed ID: 12506037
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells.
Glennie S; Soeiro I; Dyson PJ; Lam EW; Dazzi F
Blood; 2005 Apr; 105(7):2821-7. PubMed ID: 15591115
[TBL] [Abstract][Full Text] [Related]
3. Direct visualization of cross-reactive effector and memory allo-specific CD8 T cells generated in response to viral infections.
Brehm MA; Markees TG; Daniels KA; Greiner DL; Rossini AA; Welsh RM
J Immunol; 2003 Apr; 170(8):4077-86. PubMed ID: 12682237
[TBL] [Abstract][Full Text] [Related]
4. CD4+/CD25+ regulatory cells inhibit activation of tumor-primed CD4+ T cells with IFN-gamma-dependent antiangiogenic activity, as well as long-lasting tumor immunity elicited by peptide vaccination.
Casares N; Arribillaga L; Sarobe P; Dotor J; Lopez-Diaz de Cerio A; Melero I; Prieto J; Borrás-Cuesta F; Lasarte JJ
J Immunol; 2003 Dec; 171(11):5931-9. PubMed ID: 14634104
[TBL] [Abstract][Full Text] [Related]
5. Activated murine endothelial cells have reduced immunogenicity for CD8+ T cells: a mechanism of immunoregulation?
Marelli-Berg FM; Scott D; Bartok I; Peek E; Dyson J; Lechler RI
J Immunol; 2000 Oct; 165(8):4182-9. PubMed ID: 11035050
[TBL] [Abstract][Full Text] [Related]
6. Dendritic cells pulsed with exogenous hepatitis B surface antigen particles efficiently present epitopes to MHC class I-restricted cytotoxic T cells.
Stober D; Trobonjaca Z; Reimann J; Schirmbeck R
Eur J Immunol; 2002 Apr; 32(4):1099-108. PubMed ID: 11920577
[TBL] [Abstract][Full Text] [Related]
7. Derivation of HLA-B*0702 transgenic mice: functional CTL repertoire and recognition of human B*0702-restricted CTL epitopes.
Alexander J; Oseroff C; Sidney J; Sette A
Hum Immunol; 2003 Feb; 64(2):211-23. PubMed ID: 12559623
[TBL] [Abstract][Full Text] [Related]
8. DNA fusion vaccines induce targeted epitope-specific CTLs against minor histocompatibility antigens from a normal or tolerized repertoire.
Rice J; Buchan S; Dewchand H; Simpson E; Stevenson FK
J Immunol; 2004 Oct; 173(7):4492-9. PubMed ID: 15383580
[TBL] [Abstract][Full Text] [Related]
9. Deletion of naïve T cells recognizing the minor histocompatibility antigen HY with toxin-coupled peptide-MHC class I tetramers inhibits cognate CTL responses and alters immunodominance.
Hess SM; Young EF; Miller KR; Vincent BG; Buntzman AS; Collins EJ; Frelinger JA; Hess PR
Transpl Immunol; 2013 Dec; 29(1-4):138-45. PubMed ID: 24161680
[TBL] [Abstract][Full Text] [Related]
10. Allogeneic mesenchymal stem cell and mesenchymal stem cell-differentiated chondrocyte suppress the responses of type II collagen-reactive T cells in rheumatoid arthritis.
Zheng ZH; Li XY; Ding J; Jia JF; Zhu P
Rheumatology (Oxford); 2008 Jan; 47(1):22-30. PubMed ID: 18077486
[TBL] [Abstract][Full Text] [Related]
11. Presentation of acquired peptide-MHC class II ligands by CD4+ regulatory T cells or helper cells differentially regulates antigen-specific CD4+ T cell response.
Zhou G; Ding ZC; Fu J; Levitsky HI
J Immunol; 2011 Feb; 186(4):2148-55. PubMed ID: 21242518
[TBL] [Abstract][Full Text] [Related]
12. Peripheral "CD8 tuning" dynamically modulates the size and responsiveness of an antigen-specific T cell pool in vivo.
Maile R; Siler CA; Kerry SE; Midkiff KE; Collins EJ; Frelinger JA
J Immunol; 2005 Jan; 174(2):619-27. PubMed ID: 15634879
[TBL] [Abstract][Full Text] [Related]
13. Interferon-gamma-stimulated marrow stromal cells: a new type of nonhematopoietic antigen-presenting cell.
Stagg J; Pommey S; Eliopoulos N; Galipeau J
Blood; 2006 Mar; 107(6):2570-7. PubMed ID: 16293599
[TBL] [Abstract][Full Text] [Related]
14. Examination of HY response: T cell expansion, immunodominance, and cross-priming revealed by HY tetramer analysis.
Millrain M; Chandler P; Dazzi F; Scott D; Simpson E; Dyson PJ
J Immunol; 2001 Oct; 167(7):3756-64. PubMed ID: 11564792
[TBL] [Abstract][Full Text] [Related]
15. Inefficient cross-presentation limits the CD8+ T cell response to a subdominant tumor antigen epitope.
Otahal P; Hutchinson SC; Mylin LM; Tevethia MJ; Tevethia SS; Schell TD
J Immunol; 2005 Jul; 175(2):700-12. PubMed ID: 16002665
[TBL] [Abstract][Full Text] [Related]
16. Cross-dressed dendritic cells drive memory CD8+ T-cell activation after viral infection.
Wakim LM; Bevan MJ
Nature; 2011 Mar; 471(7340):629-32. PubMed ID: 21455179
[TBL] [Abstract][Full Text] [Related]
17. Differential requirements for survival and proliferation of CD8 naïve or memory T cells.
Tanchot C; Lemonnier FA; Pérarnau B; Freitas AA; Rocha B
Science; 1997 Jun; 276(5321):2057-62. PubMed ID: 9197272
[TBL] [Abstract][Full Text] [Related]
18. T cell reactivity to MHC class II-bound self peptides in systemic lupus erythematosus-prone MRL/lpr mice.
Suh CH; Freed JH; Cohen PL
J Immunol; 2003 Feb; 170(4):2229-35. PubMed ID: 12574397
[TBL] [Abstract][Full Text] [Related]
19. Incomplete activation of CD4 T cells by antigen-presenting transitional immature B cells: implications for peripheral B and T cell responsiveness.
Chung JB; Wells AD; Adler S; Jacob A; Turka LA; Monroe JG
J Immunol; 2003 Aug; 171(4):1758-67. PubMed ID: 12902475
[TBL] [Abstract][Full Text] [Related]
20. Concurrent allorecognition has a limited impact on posttransplant vaccination.
Manzo T; Hess Michelini R; Basso V; Ricupito A; Chai JG; Simpson E; Bellone M; Mondino A
J Immunol; 2011 Feb; 186(3):1361-8. PubMed ID: 21209285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
